Kolexia
Lombardi Yannis
Néphrologie
Hôpital Européen Georges Pompidou
Paris, France
75 Activités
491 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Défaillance rénale chronique Défaillance cardiaque Atteinte rénale aigüe Insuffisance rénale Hypertension artérielle Cardiomyopathie dilatée Cardiomyopathies Maladies du rein

Industries

Novartis
2 collaboration(s)
Dernière en 2019
MSD
1 collaboration(s)
Dernière en 2019
Amgen
1 collaboration(s)
Dernière en 2019
GSK
1 collaboration(s)
Dernière en 2019

Dernières activités

Prognostic Biomarkers in Kidney Transplantation: a Systematic Review and Critical Appraisal.
Journal of the American Society of Nephrology : JASN   06 décembre 2023
Correspondence on "Genomic testing for suspected monogenic kidney disease in children and adults: a health economic evaluation" by Wu et al.
Genetics in medicine : official journal of the American College of Medical Genetics   28 septembre 2023
Kidney Transplantation in Patients With AA Amyloidosis: Outcomes in a French Multicenter Cohort.
American journal of kidney diseases : the official journal of the National Kidney Foundation   22 septembre 2023
#5465 RACE-FREE EGFR EQUATION IN KIDNEY RECIPIENTS: A DEVELOPMENT AND VALIDATION STUDY
60th ERA Congress, 15-18 June 2023: Congress Abstracts   14 juin 2023
Clinical spectrum and outcome of adult patients with emphysematous pyelonephritis requiring ICU: a French multicenter retrospective cohort study
Proceedings of Reanimation 2023, the French Intensive Care Society International Congress   14 juin 2023
Race-free estimated glomerular filtration rate equation in kidney transplant recipients: development and validation study.
BMJ (Clinical research ed.)   31 mai 2023
Exome sequencing in adult nephropathy of unknown origin: a population study
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference   01 mai 2023
Additional Benefits of Rituximab and Plasma Exchange on Top of Standard Induction Therapy in Kidney Transplant Recipients With a Negative CDC Crossmatch but High Preformed Donor Specific Antibody Titer.
Transplant international : official journal of the European Society for Organ Transplantation   28 mars 2023
Stiripentol and Lumasiran as a Rescue Therapy for Oxalate Nephropathy Recurrence After Kidney Transplantation in an Adult Patient With Primary Hyperoxaluria Type 1.
American journal of kidney diseases : the official journal of the National Kidney Foundation   21 janvier 2023
Exome-First Strategy in Adult Patients With CKD: A Cohort Study.
Kidney international reports   17 décembre 2022